Virtus LifeSci Valuation

Virtus LifeSci Biotech Clinical Trls ETF -- USA Etf  

USD 31.88  0.06  0.19%

Virtus LifeSci Biotech has current Real Value of $32.08 per share. The regular price of the etf is $31.88. At this time the etf appears to be fairly valued. Macroaxis measures value of Virtus LifeSci Biotech from inspecting the etf fundamentals such as One Year Return of 42.93%, Equity Positions Weight of 99.63% and Price to Earning of 39.87times as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securites prices and their ongoing real values will draw towards each other.
 Time Horizon     30 Days    Login   to change
Virtus LifeSci Biotech Clinical Trls ETF is rated below average in price to sales as compared to similar ETFs. It is rated below average in equity positions weight as compared to similar ETFs making about  50.07  of Equity Positions Weight per Price to Sales.

Current Market Valuation

Virtus LifeSci Biotech Valuation Boundaries
Fairly Valued
April 20, 2018
31.88
Market Value
32.08
Real Value
Target Price Odds
 Above  Below  
39.07
Upside
Virtus LifeSci is not too volatile asset. Calculation of real value of Virtus LifeSci Biotech is based on 2 months time horizon. Increasing Virtus LifeSci Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Net Asset

Virtus LifeSci Net Asset Analysis
Virtus LifeSci Biotech Clinical Trls ETF is rated below average in net asset as compared to similar ETFs. Total Asset Under Management (AUM) of Sector category is currently estimated at about 74.88 Billion. Virtus LifeSci adds roughly 0.0 in net asset claiming only tiny portion of equities under Sector ETF category.
Check also Trending Equities. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.